Skip to main content

and
  1. No Access

    Article

    Postoperative chemoradiotherapy in gastric cancer: a phase I study of radiotherapy with dose escalation of oxaliplatin, 5-fluorouracil, and leucovorin (FOLFOX regimen)

    Concurrent chemoradiotherapy begins to be more and more widely accepted as a standard adjuvant treatment in gastric cancer. And oxaliplatin, leucovorin, and 5-fluorouracil (FOLFOX) also reveals to be a very ef...

    **n Wang, Yongsheng Wang, Meng Qiu, Qiu Li, Zhi-** Li, Bing He in Medical Oncology (2011)

  2. No Access

    Article

    Predictive value of pretreatment positron emission tomography/computed tomography in patients with newly diagnosed extranodal natural killer/T-cell lymphoma

    The role of 18Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) in extranodal natural killer/T-cell lymphoma (ENKL) is not well established. This study aimed to investigate the prognost...

    Bing Bai, Hui-Qiang Huang, Qi-Chun Cai, Wei Fan, **ao-**ao Wang in Medical Oncology (2013)

  3. No Access

    Article

    Sorafenib in combination with transarterial chemoembolization and radiofrequency ablation in the treatment for unresectable hepatocellular carcinoma

    The purpose of this study is to assess clinical efficacy and safety of sorafenib combined with transarterial chemoembolization (TACE) and radiofrequency ablation (RFA) on patients with unresectable hepatocellu...

    Yong Li, You-Bing Zheng, Wei Zhao, Bing Liu, Bao-Shan Hu, Xu He in Medical Oncology (2013)

  4. No Access

    Article

    Prognostic value of serum vascular endothelial growth factor receptor 2 response in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

    We aimed to elucidate whether serum VEGFR2 concentration before and after transarterial chemoembolization (TACE) can predict survival in patients with unresectable hepatocellular carcinoma (HCC). Serum VEGFR2 ...

    You-Bing Zheng, Qing-Wen Meng, Wei Zhao, Bing Liu, Jian-Wen Huang in Medical Oncology (2014)

  5. Article

    Open Access

    Clinical outcomes of CyberKnife stereotactic body radiotherapy for peripheral stage I non-small cell lung cancer

    The aim of this study was to evaluate the clinical outcome of CyberKnife stereotactic body radiotherapy (SBRT) for patients with stage I non-small cell lung cancer (NSCLC). Fifty patients with peripheral stage...

    Ze-Tian Shen, **n-Hu Wu, Bing Li, **-Xu Zhu in Medical Oncology (2015)